companydata.dkcompanydata.dk

NOVOZYMES A/S: Financial statements 2018

CVR: 10007127

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

NOVOZYMES A/S (CVR 10007127) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 14,390,000,000 and a net result of DKK 3,227,000,000 compared with DKK 3,120,000,000 the year before. That is a decrease of 1% compared with the year before. The profit margin was 22.4%. Equity in the 2018 report amounted to DKK 11,438,000,000. The solvency ratio was 58.1%.

Revenue
DKK 14,390,000,000
Gross Profit
DKK 8,255,000,000
Profit/Loss
DKK 3,227,000,000
Equity
DKK 11,438,000,000
Total Assets
DKK 19,697,000,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201814.4B8.3B3.2B11.4B-
201714.5B8.4B3.1B11.3B-
201614.1B8.1B3.1B11.7B-
201514B8.1B2.8B11.6B-
201412.5B7.1B2.5B11.3B-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

NOVOZYMES A/S publishes interim reportNov 16, 2018

NOVOZYMES A/S has published its interim report for the period January 1, 2018 to September 30, 2018.

NOVOZYMES A/S publishes interim reportSep 11, 2018

NOVOZYMES A/S has published its interim report for the period January 1, 2018 to June 30, 2018.

NOVOZYMES A/S publishes interim reportJul 18, 2018

NOVOZYMES A/S has published its interim report for the period January 1, 2018 to March 31, 2018.

NOVOZYMES A/S: The 2017 annual report is outMar 21, 2018

NOVOZYMES A/S has published its annual report for 2017. Revenue came to DKK 14,531,000,000, and the net result was DKK 3,120,000,000.

Patricia Malarkey joins the board of NOVOZYMES A/SMar 13, 2018

As of March 13, 2018, Patricia Malarkey has joined the board of directors of NOVOZYMES A/S.

Prisca Havranek-Kosicek joins NOVOZYMES A/S as directorFeb 1, 2018

As of February 1, 2018, Prisca Havranek-Kosicek is registered as director of NOVOZYMES A/S.

About NOVOZYMES A/S

NOVOZYMES A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2000. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The management consists of Ester Baiget Arnau and Rainer Chapour Lehmann. The board consists of Cornelis de Jong (chair), Heine Dalsgaard, Frederikke Rose Spenner and Kasim Kutay. The company is owned by Novo Holdings A/S and BlackRock, Inc.. The company has 3,508 employees (2026). In 2025, the company reported revenue of EUR 4,157,600,000 and a net result of EUR 583,600,000 compared with EUR 305,800,000 the year before. Equity in the 2025 report amounted to EUR 10,855,200,000.

Source: annual report 2025, Danish Business Authority